Results 21 to 30 of about 135,997 (338)

Patient-Reported Side Effects of Intradetrusor Botulinum Toxin Type A for Idiopathic Overactive Bladder Syndrome [PDF]

, 2010
Objective: The aim of the study was a prospective assessment of patient-reported side effects in an open-label study after intradetrusor botulinum toxin injections for idiopathic overactive bladder (OAB). Patients and Methods: Botulinum toxin A injection
Mayer, Margit E., Yasmin Hocaoglu, Alexander Buchner, Hocaoglu, Yasmin, Buchner, Alexander, Christian G. Stief, Bauer, Ricarda M., Alexander Roosen, Stief, Christian G., May, Florian, Christian Gratzke, Ricarda M. Bauer, Margit E. Mayer, Gratzke, Christian, Florian May, Roosen, Alexander   +15 more
core   +1 more source

Uses of botulinum toxin in the management of patients with movement disorders: a national survey from India

Annals of Movement Disorders, 2020
Objective: The aim was to assess the opinion of the movement disorder society of India members regarding the uses of botulinum toxin in clinical practice.
Ashwin K Panda, Sanjay Pandey
doaj   +1 more source

Development of a technique for DNA detection and identification of toxigenic strains of Clostridium botulinum types A, B, E by the Real-Time PCR method

Вестник войск РХБ защиты, 2023
Botulism is dangerous toxic infection caused by a toxin produced by the bacterium Clostridium botulinum. The mortality rate from botulism can reach 70% of all cases of illness in case of untimely initiation of treatment.
D. S. Yanov, A. V. Kuznetsovskiy, M. I. Dubrovin, A. V. Mironin, N. V. Onuchina, A. V. Filippov   +5 more
doaj   +1 more source

Botulinum toxin a in the treatment of blepharospasm - A 10-year experience [PDF]

, 2005
To evaluate the long-term effect of botulinum toxin type A (BTX) in the treatment of blepharospasm, a retrospective analysis was conducted from the patients seen at the Movement Disorders Clinic of the Department of Neurology, Hospital das Clinicas ...
Goncalves, LR, Chien, HF, Silveira-Moriyama, L, Lilian R. Gonçalves, Laura Silveira-Moriyama, Barbosa, ER, Egberto R. Barbosa, Hsin Fen Chien   +7 more
core   +1 more source

Vasculitis with panniculitis following botulinum toxin A injection for cosmetic use

Dermatology Practical & Conceptual, 2016
Botulinum toxin A injection is performed most frequently for facial rejuvenation all over the world. Some bizarre and severe side effects have been reported after botulinum toxin A injection.
Nastaran Namazi, Reza M. Robati, Sahar Dadkhahfar, Anoush Shafiee, Farahnaz Bidari-Zerehpoush   +4 more
doaj   +1 more source

The whole truth about botulinum toxin – a review

Advances in Dermatology and Allergology, 2019
Treatment with botulinum toxin is widely viewed as safe, effective and largely devoid of serious side effects. There are two classes of Botox-related adverse events – transient and benign events, and potentially serious events.
H. Witmanowski, K. Błochowiak
semanticscholar   +1 more source

Botulinum Toxin in Movement Disorders: An Update

Toxins, 2021
Since its initial approval in 1989 by the US Food and Drug Administration for the treatment of blepharospasm and other facial spasms, botulinum toxin (BoNT) has evolved into a therapeutic modality for a variety of neurological and non-neurological ...
Charenya Anandan, J. Jankovic
semanticscholar   +1 more source

Botulinum Toxin Injection for the Treatment of Upper Esophageal Sphincter Dysfunction

Toxins, 2022
Dysphagia associated with upper esophageal sphincter (UES) dysfunction remarkably affects the quality of life of patients. UES injection of botulinum toxin is an effective treatment for dysphagia. In comparison with skeletal muscles of the limb and trunk,
Pengxu Wei
doaj   +1 more source

Botulinum Toxin as Preventive Treatment for Migraine: A Randomized Double-Blind Study [PDF]

, 2009
Aim: To determine if botulinum toxin type A (BoNT-A) injections can reduce the frequency and severity of migraines. Methods: Patients (n = 127) were randomized to receive placebo or two doses of BoNT-A (Dysport (R)). The primary endpoint was reduction in
Toelle, Thomas, Straube, Andreas, Ceballos-Baumann, Andres, Volker Pfaffenrath, Petri, Susanne, Pfaffenrath, Volker, Susanne Petri, Thomas Tölle, Ulrich Stefenelli, Andres Ceballos-Baumann, Stefenelli, Ulrich, Andreas Straube   +11 more
core   +1 more source

Treatment of chronic pain associated with nocturnal bruxism with botulinum toxin. A prospective and randomized clinical study

Journal of Clinical and Experimental Dentistry, 2017
Background To evaluate the role of botulinum toxin type A (BTX-A) in the treatment of pain associated with nocturnal bruxism. Material and Methods Fifty subjects reporting nocturnal bruxism were recruited for a randomized clinical trial.
Hessa M Al-Wayli
semanticscholar   +1 more source